EcoDrugPlus

5-Hydroxytryptamine Receptor 5a

Ensembl ID : ENSECRG00000004764
Gene Symbol: HTR5A
3 Cross references
216 Possible Orthologues:

60s Ribosomal Protein L10

Ensembl ID : ENSECRG00000018805
Gene Symbol: LOC114660507
3 Cross references
408 Possible Orthologues:

60s Ribosomal Protein L17

Ensembl ID : ENSECRG00000008193
Gene Symbol: LOC114654460
3 Cross references
325 Possible Orthologues:

60s Ribosomal Protein L18

Ensembl ID : ENSECRG00000003796
Gene Symbol: LOC114653172
3 Cross references
376 Possible Orthologues:

60s Ribosomal Protein L18

Ensembl ID : ENSECRG00000014717
Gene Symbol: LOC114666634
3 Cross references
376 Possible Orthologues:

60s Ribosomal Protein L26

Ensembl ID : ENSECRG00000012885
Gene Symbol: LOC114660182
3 Cross references
477 Possible Orthologues:

Abl Proto-Oncogene 1, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSECRG00000014578
Gene Symbol: ABL1
3 Cross references
204 Possible Orthologues:

Adam Metallopeptidase Domain 17

Ensembl ID : ENSECRG00000009845
Gene Symbol: ADAM17
3 Cross references
283 Possible Orthologues:

Akt Serine/threonine Kinase 2

Ensembl ID : ENSECRG00000000061
Gene Symbol: AKT2
3 Cross references
256 Possible Orthologues:

Akt Serine/threonine Kinase 3

Ensembl ID : ENSECRG00000013522
Gene Symbol: AKT3
3 Cross references
203 Possible Orthologues:

Atp Binding Cassette Subfamily B Member 1

Ensembl ID : ENSECRG00000014287
Gene Symbol: ABCB1
3 Cross references
163 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 1

Ensembl ID : ENSECRG00000016748
Gene Symbol: ABCC1
3 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).